Emerald Acquisition’s Horizon Therapeutics HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
KCM
Emerald Acquisition's HZNP Position: Q3 2016 in Review
Emerald Acquisition reduced its Horizon Therapeutics (HZNP) stake by 23% in Q3 2016, selling an estimated $1.14M and leaving 191,322 shares worth $3.47M. The position accounts for 0.01% of the portfolio, ranked #1440.
Emerald Acquisition first reported a position in HZNP in Q2 2016 and has held it in 2 quarters since. The position peaked at $4.12M in Q2 2016. 233 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.
- Emerald Acquisition held 191,322 shares of Horizon Therapeutics worth $3.47M as of Q3 2016.
- Emerald Acquisition sold 58,584 Horizon Therapeutics shares in Q3 2016, an estimated $1.14M.
- Horizon Therapeutics made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1440 holding.
- Emerald Acquisition first reported a position in Horizon Therapeutics in Q2 2016 and has held it in 2 quarters since.
- Emerald Acquisition's Horizon Therapeutics position peaked at $4.12M in Q2 2016.
- 233 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q3 2016.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.